Literature DB >> 8137241

Constitutive DNA binding of the low mobility forms of the AP-1 and SP-1 transcription factors in HL60 cells resistant to 1-beta-D-arabinofuranosylcytosine.

S S Kolla1, G P Studzinski.   

Abstract

DNA binding of the AP-1 transcription factor, a dimer of jun-fos or jun-jun proteins, is regulated during monocytic differentiation of HL60 cells. The abundance of AP-1 complexes capable of binding to DNA increases and complexes with slow electrophoretic mobility appear after exposure of HL60 cells to 1,25-dihydroxyvitamin D3. Similar changes are seen in the SP-1 transcription factor. In contrast, variants of HL60 cells that are resistant to both 1,25-dihydroxyvitamin D3 and 1-beta-D-arabinofuranosylcytosine constitutively express the slowly migrating AP-1 and SP-1 complexes which are found only in the differentiated parental HL60 cells. Because this form of AP-1 complex is highly phosphorylated, the data show that altered phosphorylation of at least two transcription factors is associated with resistance to 1-beta-D-arabinofuranosylcytosine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8137241

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

1.  Induction of kinase suppressor of RAS-1(KSR-1) gene by 1, alpha25-dihydroxyvitamin D3 in human leukemia HL60 cells through a vitamin D response element in the 5'-flanking region.

Authors:  X Wang; T-T Wang; J H White; G P Studzinski
Journal:  Oncogene       Date:  2006-05-29       Impact factor: 9.867

2.  Response of Djun and Dfos mRNA abundance to signal transduction pathways in cultured cells of Drosophila melanogaster.

Authors:  X Xia; E S Goldstein
Journal:  Mol Biol Rep       Date:  1999-08       Impact factor: 2.316

3.  The requirement for and changing composition of the activating protein-1 transcription factor during differentiation of human leukemia HL60 cells induced by 1,25-dihydroxyvitamin D3.

Authors:  Xuening Wang; George P Studzinski
Journal:  Cancer Res       Date:  2006-04-15       Impact factor: 12.701

4.  Cellular pharmacology of a liposomal preparation of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine, a lipophilic derivative of 1-beta-D-arabinofuranosylcytosine.

Authors:  D H Horber; H Schott; R A Schwendener
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

5.  Cell cycle-dependent cytotoxicity and induction of apoptosis by liposomal N4-hexadecyl-1-beta-D-arabinofuranosylcytosine.

Authors:  D H Horber; P von Ballmoos; H Schott; R A Schwendener
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.